Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Clarma Capital is a venture capital firm established to invest in European life sciences startups, particularly in medical devices, medicinal products, and diagnostic innovation. Founded with the mission to nurture breakthroughs in the life sciences sector, Clarma Capital operates from multiple locations, including London, Switzerland, Dublin, and Central Europe. The firm is dedicated to supporting seed and early-stage companies that are developing regulated products based on solid scientific principles.
Currently, Clarma Capital is led by a team of experienced professionals, including Managing Partner Martyn Eeles, who has a background in both venture capital and the life sciences. The firm emphasizes collaboration with incubators, innovation hubs, and academic institutions to enhance its investment strategy. Clarma Capital is focused on companies that have the potential to significantly impact healthcare, aiming to create value through operational support, strategic partnerships, and regulatory guidance.
Clarma Capital invests primarily in seed and early-stage life sciences companies across Europe, specifically targeting those developing regulated products in sectors such as medical devices, medicinal products, and diagnostics. The firm seeks startups that demonstrate significant addressable markets, capable management teams, and clearly defined exit strategies, preferably through acquisitions or mergers. Their investment strategy is rooted in scientific rigor, emphasizing the importance of solid scientific principles in the development of products.
Collaboration is a key component of Clarma Capital's approach, as the firm actively partners with incubators, innovation hubs, and academic institutions to identify promising investment opportunities. Clarma Capital values companies that not only have innovative solutions but also possess a commercially minded management team that can navigate the complexities of the healthcare market. The firm’s focus on regulated products ensures that their investments are aligned with the highest standards of safety and efficacy.
Martyn Eeles - Managing Partner & Founder. Martyn has extensive experience in venture capital and the life sciences sector, with a focus on identifying and nurturing innovative startups.
Clara Ezed - Partner. Clara brings a wealth of knowledge in investment strategies and has a strong background in supporting early-stage companies in the healthcare space.
Milos Milicsevics - Partner. Milos is known for his expertise in the biotech sector and has a track record of successful investments in life sciences.
Dr. László Szabó - M.D. Venture Partner. Dr. Szabó has a medical background and provides valuable insights into the regulatory landscape and product development processes.
Alain Bindels - Venture Partner. Alain has significant experience in the European healthcare market and contributes to the firm's strategic direction.
Mary Jo Gorman, MD - Senior Advisor. Dr. Gorman offers her expertise in medical innovation and strategic partnerships.
Okeibuno Okonkwo, MD - Senior Advisor. Dr. Okonkwo provides insights into clinical development and regulatory affairs.
To pitch Clarma Capital, founders should send an email to info@clarmacapital.com. It is advisable to include a concise overview of the business model, market opportunity, and the qualifications of the management team in the pitch deck. Clarma Capital appreciates clear and well-structured presentations that outline the startup's potential for growth and impact in the life sciences sector.
Response times may vary, but founders should expect to receive feedback within a few weeks. Warm introductions are preferred, as they can enhance the likelihood of a favorable review.
What types of companies does Clarma Capital invest in?
Clarma Capital focuses on seed and early-stage life sciences companies in Europe, particularly those developing regulated products in medical devices, medicinal products, and diagnostics.
What is the typical investment stage for Clarma Capital?
The firm primarily invests in seed and Series A stages, targeting startups that are in the early phases of product development.
How does Clarma Capital support its portfolio companies?
Clarma Capital provides hands-on support, including follow-on funding, strategic partnerships, operational efficiency improvements, business development, and regulatory guidance, especially in navigating FDA-related processes.
What are the key criteria for investment?
Clarma Capital looks for companies with significant addressable markets, capable management teams, and clear exit strategies. They prioritize scientific grounding and the potential to change the standard of care.
How can founders pitch to Clarma Capital?
Founders can reach out via email at info@clarmacapital.com to discuss potential investment opportunities and should prepare to present their business model, market opportunity, and management team's qualifications.
What geographic areas does Clarma Capital focus on?
The firm invests in life sciences startups located in Europe, with a particular emphasis on regions such as London, Switzerland, Dublin, and Central Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.